Croakey

Hospital management is too important to leave to medicos

A call for hospital management to return to arrangements of the past has drawn fire from former senior health service manager Michael Moodie and health economist Professor Gavin Mooney.

They write:

“John Graham’s suggestion for saving NSW hospitals, as outlined in his recent Centre for Independent Studies monologue, dreams of hospitals managing their own affairs unfettered by outside interference. His piece is called ‘The past is the future for public hospitals’.

He argues in essence: just let us (primarily doctors) get on with it – as we used to do – and all will be well.

The arrogance and lack of ‘back-sight’ in learning from the past are stunning.

We are not going to speculate on how to address the problems of NSW hospitals beyond arguing that Graham’s suggestion is not the way to go.

What is at stake is the question of who has the power to decide how resources in hospitals and health services more generally are used.

Do we want another Bristol or another King Edward Memorial Hospital?  Are doctors to be left in charge? They are trained in medicine but not hospital management which is a major and important discipline in its own rights. We risk producing a culture of ‘medocrats’ and that as the Bristol Inquiry indicated is to be avoided.

The logic of Area Health Services is to address the health of a population not just the patients of a hospital. So what is the role of the hospital in the community under this view from the past? How are questions of equity to be addressed?

Central to any recommendation on governance of our public hospitals must be a recognition of three things.

First hospitals are responsible for allocating resources – for example, setting priorities within the funds available for example – as well as treating patients. Second there needs to be some clear explicit mechanism for ensuring that the culture of hospitals is genuinely conducive to good patient care. And three, hospitals are about power, both power within the hospital and power in the health service more widely.

Whatever else we can learn from Bristol and King Edward’s – and surely from these there must be a learning process – it is that ‘internal’ auditing of hospitals is simply not good enough.

There needs to be openness in all aspects of both patient safety and resource management. Ideally if hospitals  are to serve communities, there needs to be accountability to the citizens in the community they serve such as through citizens’ juries as one of us (MM) organised in the south west of WA [This book has more details].

Graham bemoans the advent of Medicare: “The ideologically driven decision to allow all comers to be treated free regardless of means fundamentally changed the dynamic that underpinned the successful operation of the public hospital system.”

It certainly did. But unlike Graham we welcomed Medicare and want to defend it particularly given the current attempt to undermine it in the floating of Medicare Select by the NHHRC.

Given the ideologically driven ideas in proposing a return to the past in Graham’s CIS paper, it is superfluous to ask what concerns he might have in his proposal for equity (which interestingly was given a big tick in that WA citizens’ jury).”

Would Medicare Select deliver a mental health boost?

In recent weeks, Croakey has run several articles examining the potential pros and cons of the Medicare Select concept floated by the National Health and Hospitals Reform Commission in its final report.

Now a senior mental health advocate, Sebastian Rosenberg, is weighing into the debate, asking what such a model might mean for those with mental health problems. He is a Senior Lecturer at the Brain and Mind Research Institute and Deputy CEO of the Mental Health Council of Australia.

He writes:

““Plus ca change” the French say – the more things change, the more they stay the same. That is the justifiable concern among many in the mental health sector as the Federal and State Governments contemplate the recommendations of the National Health and Hospital Reform Commission.

In mental health, the status quo just isn’t an option.

Ten years of so-called mental health reform has seen Australia fail to lift the rate of access to care for people with a mental illness – 38% of people with a mental illness were in care in 1997 and 35% in 2007.

So debates about concepts like Medicare Select take on particular significance.  For areas of health that are well serviced, the old axiom not to fix something that ain’t broke may well apply.  Rates of access to care in other chronic illness are more like 70-80%, with the majority of people getting the care they need.

This is clearly not the case in mental health and has spurred calls for fundamental reform.  It is no surprise that some of the leading proponents (occupying a telephone booth near you) of Medicare Select highlight mental health as a key potential beneficiary of a new approach.

But the motivations underpinning their support vary.  For some, Medicare Select represents a chance to promulgate an individualised approach to health care, taking funding decisions out of the hands of health professionals or the nanny-state, and giving choice instead to each consumer.

These supporters talk of ‘cashing out entitlements’ and giving each consumer ‘leverage’ to buy tailored packages of care.  This is certainly a model which exists in the construct of packages of care for the support of profoundly disabled children, though the extent to which these packages are really based on understanding the costs of care is debatable.

What is clear is that in such situations, governments work with families to develop packages of care that can be worth hundreds of thousands of dollars in order to enable health, community and other services to be available.  These packages are regular features of disability support but, of course, there aren’t lots of them.

So what are the entitlements of a person with a mental illness?  While there is plenty of evidence about what treatments, services and programs work, what is the right package of care for a young person showing early signs of psychosis?  How much does it cost?  How will a person with a mental illness know what to buy? And who will ensure they get what they pay for?

Other mental health supporters of Medicare Select seem to come from a more secular school. They would simply point out that we need more money and more services provided in new ways to new clients.  Attracting some of the missing 65% into care will almost certainly cost more than the mental health system currently spends.  And much of this spending will not be in the ‘health’ system but more broadly, in a range of community services, some clinical, some psycho-social.

Medicare Select is seen through this lens as being a vehicle by which to drive a general argument that business as usual won’t wash and this is completely understandable.

But would establishing Medicare Mental Health Select, by pooling funds (however calculated) really drive the establishment of new models of service provision?  If we build it, will they come?

This question really requires more analysis.  It is a business question as much as a health question.  The New England Journal of Medicine again published evidence of the benefits of collaborative care and the drawbacks of fee-for-service medicine.

Would a Medicare Select approach to funding drive new models of employment and payment for health professionals to work collaboratively?  Would it end the cycle of fruitless incentives which have failed to entice mental health professionals out of metro areas and into the bush?  Which organisations or new collaborations can we identify who might be willing to take on the business of meeting the holistic needs of people with a mental illness?  What happened in Holland – did new mental health service providers emerge?

Despite the recent prominence of mental health as an issue, its consideration by CoAG, the Reform Commission and repeated investigations by the Senate and others, it is still reasonable to suggest that Australia remains in crisis.

Unless the Federal Government decides to pursue fundamental reform arising from the Commission’s recommendations, then some tinkering of responsibilities between the Federal and State Governments is the likely minimalist outcome of current deliberations.  It is ironic that is the precisely the community-based mental health services that are most critically needed that fall right into the grey area of responsibilities now. There is some evidence that some state governments may be withdrawing from this field in anticipation of a Federal takeover.

Perhaps the real allure of a concept like Medicare Select is that it could end the often tragically disconnected series of services that passes for our mental health ‘system’.  The programs which work in health offer integrated care.  Financial planning services offered to parents in children’s hospitals, employment officers working in psychiatric wards of a Melbourne hospital.  These are exceptional glimpses into a system of care that attempts to manage a whole person, rather than just a limb or a symptom.

I am quite sure that mental health consumers and carers don’t care a jot for who holds the money or which level of government runs which type of service.  The current debate about health reform needs to be about more than this.  In mental health it needs to be about establishing evidence-based sustainable models of community care in which health, employment, education and other services each play a role.

For mental health in Australia, ‘plus ca change’ just isn’t an option. And if Medicare Select can drive reform then it deserves support.”

• For more Croakey posts on Medicare Select, see here, here, here, here, and here, as well as this Crikey piece by John Menadue.

Some safety lessons from US health care

The United States health system often cops a bad press, but it has some lessons for us when it comes to reporting on quality, says our correspondent in Washington, Dr Lesley Russell.

She writes:

“Last week the 2009 annual report from the National Committee for Quality Assurance  (NCQA) was released.

The NCQA is a private, not-for-profit organization that was founded in 1990. The State of Health Care Quality report monitors and reports annually on performance trends over time, tracks variations in patterns of care, and provides recommendations for future quality improvement.

This report highlights how valuable an independent analysis of quality measures for private health insurance plans and the two government-funded plans, Medicare and Medicaid, is for everyone involved – policy makers, budget managers, health care services and professionals and patients.  The analysis is based on data that the health plans report voluntarily.

This year the results are disappointing, as they show that for the third year in a row, the quality of US health care has not improved across many key measures of clinical quality.

There are probably multiple reasons for the flat results of 2009, but a key factor is the lagging US economy which has led purchasers to focus more on cost than on quality.  Insurance plans have naturally followed suit and paid more attention to negotiating discounts and less to improving performance. And the most effective tool — tying payments to performance — is not being well utilised enough, especially by the Medicare program.

A related issue is that a many Americans lose their jobs, there is greater demand on Medicaid programs at a time when stets budgets are under maximum pressure.

But the report also shows that quality care is not necessarily expensive care, which does mean that in difficult financial times, improvements in quality should still be possible

Failure to jump-start quality improvement carries a significant price. This report estimates that improvements made in years past have saved between 165,000 and 272,000 lives, and there is much more progress possible. If all health plans performed at the same level as the top 10 percent of plans (the 90th percentile), between 49,400 and 115,300 deaths could be prevented each year, along with billions saved in health care spending.

The NCQA goes further with the data which is reported to them  – they rank the plans and publish the results every year in USA Today and on their website.

This transparency is not without its downside, and the private health insurance funds, under pressure from promised health care reforms, have been doing their best to airbrush their failing results.

As the NCQA President states in the preface, “This report provides ample evidence of the need for reform. ……These warning lights cannot be ignored.”

Will we ever get to such openness in Australia?  And would we feel that health care reform was a little more urgent if we had some longitudinal data to highlight where quality could be improved, and lives and dollars saved?”

Lesley Russell is the Menzies Foundation Fellow at the Menzies Centre for Health Policy at the University of Sydney and the Australian National University, and a Research Associate at the US Studies Centre, University of Sydney. She is currently a Visiting Fellow at the Center for American Progress in Washington DC.

More on Dr Coca-Cola

For those who’ve been following the Croakey debate on the “healthy” rebranding of soft drinks, here’s an interesting story from the LA Times health blog following up the implications of health and medical organisations taking funding from soft drink companies and other vested interests.

It turns out the doctors aren’t the only ones taking Coca-Cola’s money. Believe it or not – dentists have too.

It’s enough to make your teeth ache.

In case you need some light relief on a Friday

Years ago, I wrote a story about the use of music in operating theatres to create the right ambience for concentration.

This, however, is something else. In case it’s been a long week….

YouTube Preview Image

I will spare you the colorectal surgeon song.

Well, maybe not.

YouTube Preview Image

There is plenty more where they came from, but I will stop now…

Has cancer screening been oversold? Cancer Council responds

The New York Times, as previously mentioned, is reporting a shift in screening policy at the the American Cancer Society, which is now saying that the benefits of early detection of  many cancers, especially breast and prostate, have been “overstated”.

“We don’t want people to panic,” Dr Otis Brawley, the Society’s chief medical officer told the NYT. “But I’m admitting that American medicine has overpromised when it comes to screening. The advantages to screening have been exaggerated.”

The LA Times has another slant on the story.

Professor Ian Olver, CEO of Cancer Council Australia, says it is important to consider the pros and cons of screening for each type of cancer, rather than making blanket statements.

He writes:

“It is not helpful to bundle prostate and breast cancer together in a discussion about the benefits of screening. The aim of screening is to diagnose cancer or pre-cancerous conditions early to significantly improve treatment outcomes. It should never be interpreted as guaranteeing cure for all individuals.

The term “over-diagnosis” can apply to people who have cancers detected by screening but who would have died of something else before the cancer would have been detected in the absence of screening. Obviously very slow-growing cancers would make over-diagnosis more likely.

After many years of mammographic screening for breast cancer, the International Agency for Research in Cancer has estimated that the reduction in the death rate from breast cancer in the main target group of 50 to 69 year olds is 35%, a significant mortality benefit, but not without some cost.

The estimate from the initial mammography trials of over-diagnosis is 2 to 3% (that is cancers that would not have progressed if left untreated). Adding in the pre-invasive DCIS (ductal carcinoma in situ) the range of estimates of over-diagnosis is around 9%. However, this still means that the vast majority of detected cancers did need treatment and that lives were saved.

Prostate cancer is quite different. There is no history of population screening programs to study. Two large randomised trials of PSA testing of asymptomatic men from last year had differing results.

No change in the death rate from prostate cancer was found in an American study while in the European study a 20% relative decrease in mortality was reported.

The overtreatment rate in this study was that for every 49 men who underwent prostatectomy only one life was saved, yet each was at risk of the side effects of impotence and incontinence.

Over-diagnosis and over-treatment are why Cancer Council Australia and a number of other health groups recommend PSA screening be an individual choice. Further research should be encouraged in this and other cancers to find better screening tests and tests that will identify indolent cancers which don’t need immediate treatment.

So, although it has always been known that not every individual will benefit from screening, in the proven population screening programs, for cervical cancer, breast cancer and colorectal cancer, the likelihood of reducing deaths from these diseases outweighs the chance of over-diagnosis.

Nonetheless individuals need to be informed of both the risks and benefits.

It would be a pity if doubts about over-diagnosis discouraged participation in these programs by the groups most likely to benefit or dissuaded government from completing the roll-out of the colorectal screening program,  so that it could not reach its full potential of saving 30 Australian lives each week.”

The soft drink wars heat up

The debate between Derek Yach of PepsiCo and public health sceptics is being watched from afar.

Obesity control expert Professor Boyd Swinburn has sent in his observations while travelling in the US. He writes:

“I am currently in Boston and read with interest the comments about Derek Yach and Pepsi’s PR mission to Australia.

The TV in the US is currently carrying a series of advertisements about a regular Mom complaining that the government is thinking about raising taxes on foods and drinks (actually the talk is only about taxes on sugar-sweetened sodas).

“They say its only going to be pennies, and it may not matter to those people in Washington but it matters to me when I am struggling to feed my family”. Who is behind the ads: an outfit called Americans Against Food Taxes.

And who is behind this front group: Pepsi Co and all the other usual suspects.

One of the most powerful influences big food has is in undermining public health initiatives. Pretending to be the good guy at the same time gives it an even greater influence over government as we have recently seen with the softly, softly Preventative Health Taskforce report.

Derek used to speak  for the benefit of public health, now he speaks for the benefit of food giants.”

• Boyd Swinburn is Professor of Population Health, and Director, WHO Collaborating Center for Obesity Prevention

PepsiCo responds…

As previously mentioned in Croakey posts and in this Crikey story, a tobacco control advocate turned senior PepsiCo executive, Derek Yach, recently debated public health nutritionist Rosemary Stanton at the University of Sydney. He has asked for right of reply to the Crikey piece.

He writes:

“The pity is that Melissa clearly did not absorb the objective data I offered re modest but important examples of change across food companies (from 60% less calories sold in schools in the USA; to tons of less salt in many products in the UK; to 90& reductions in certain ads to kids across Europe; to 30 000 products reformulated for many nutrients; to real impacts of portion sizes on total calories consumed)…all the data being measured and mostly independently audited!

Many of these changes do not come with increased profits in the short term and are part of deep structural changes underway across industry. They include responding to the World Health Organization’s call for support of the Global Strategy on Diet and Physical Activity; developing coordinated approaches across many multinationals to tackle a variety of nutrition issues; and stepping up investments in innovation.

Further, to call addressing hunger a distraction is the very worst type of cynicism. I attach our CEO’s speech from last week at the World Food Prize on this. Some might call it a giant distraction–most I work with regard it as an imperative we cannot and must not avoid tackling!

Melissa would do well to relisten to the debate and take note of the above points as well as many impediments to progress in tackling obesity that require more effective actions by governments, NGOs and individuals. For Australia this includes fully supporting the new Preventative Task Force recommendations.”

A cancer story that will set the cat among the pigeons

Gina Kolata has just published a story in the New York Times that is going to create international waves which will be felt for some time.

She reports that the American Cancer Society – a longtime advocate for most cancer screening – “is now saying that the benefits of detecting many cancers, especially breast and prostate, have been overstated”.

She says that the Society is quietly working on a message, to put on its Web site early next year, to emphasise that screening for breast and prostate cancer and certain other cancers can come with a real risk of overtreating many small cancers while missing cancers that are deadly.

“We don’t want people to panic,” said Dr Otis Brawley, chief medical officer of the cancer society. “But I’m admitting that American medicine has overpromised when it comes to screening. The advantages to screening have been exaggerated.”

At one level, you could say that this is not particularly new or exciting. Many people – including leading epidemiologists and public health researchers – have been saying much the same thing for quite a while, even though the message still doesn’t seem to have permeated the mainstream consciousness.

Nor is it particularly contentious that people should be told of the potential harms of screening as well as the potential benefits (although many public health campaigns continue to play up the potential benefits without mentioning the other).

Why this story will make waves is that it’s the American Cancer Society speaking up AND the Society appears to be lumping breast and prostate cancer in the same basket.

It is going to be very interesting to watch how people (ie mammogram advocates and funders, cancer organisations, doctors, the public health brigade and the general public) respond. Watch this space….

Has medical journalism sold its soul?

That’s the title of an opinion piece that an American professor of medicine, Nortin Hadler, has written for ABC News in the US.

Hadler argues that “health journalism is more beleaguered than most other specialties by the financial crunch that faces the entire Fourth Estate”, and is particularly alarmed by the influence of sophisticated medical marketing upon the media’s health coverage.

You can read his article in full here.

Hadler wrote “Worried Sick: A Prescription for Health in an Overtreated America” (which I reviewed last year for the Medical Journal of Australia) and “The Last Well Person.”